Open, single-arm phase II study assessing efficacy of Zarnestra [tipifarnib] combined with tamoxifen in patients with advanced or metastatic breast cancer expressing the estrogen and/or progesterone receptor
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2005
At a glance
- Drugs Tamoxifen; Tipifarnib
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 30 Oct 2005 New trial record.